Navigation Links
ImpactRx Releases 2010 Oncology Promotion Report
Date:1/31/2011

MOUNT LAUREL, N.J., Jan. 31, 2011 /PRNewswire/ -- ImpactRx, a pioneer in tracking and evaluating pharmaceutical promotion on the prescribing behavior of physicians, completed its annual review of the detailing efforts of pharmaceutical/biotech sales representatives in oncology offices.  The results have just been published in the January 2011 edition of Oncology Business Review.

ImpactRx's mobile pharmaceutical market research system offers a longitudinal network of 475 oncologists who use iPhone technology and proprietary software to provide real-time data about sales representative promotion, meeting and event participation and patient treatment options.  This year the data was supplemented with research into physicians' online behavior provided through a joint offering ImpactRx has with comScore, a global leader in measuring digital traffic and readership.  The result is a unique view of the promotional landscape in the fast-paced and ever-changing oncology market, helping pharmaceutical companies make the most of every minute with key physicians.

According to Richard Altus, President and CEO of ImpactRx, "Given the recent changes in the pharmaceutical and biotech industries, face time with oncologists is more valuable than ever.  This data helps refine brand and targeting strategies to ensure that the right message gets to the right physicians, providing an optimized and powerful marketing strategy."

Click here http://www.impactrx.com/pdf/OBR_93850_IMPACTRX.pdf  to download "The 3rd Annual Outlook on the Pharmaceutical Promotional Landscape within Oncology".

Key data highlighted in the article includes:

  • Share of Attention – Sales Representative Oncology Product Details 2006-2010
  • Top 25 Products Detailed by Sales Representatives 2009/2010
  • Oncology Sales Force Top Tier Rating 2010
  • Reach of Healthcare Websites  (Jan – Sept 2010)
  • Average Number of Visits per Month (Jan – Sept 2010)

  • About ImpactRx

    Founded in 2000 and headquartered in Mount Laurel, NJ, ImpactRx's longitudinal panel of high prescribing, smart phone-connected physicians is the exclusive source of continuously captured promotion and treatment data.  Through its proprietary methodology, the Company captures annually one million details and three million treatment decisions, fueling its unique industry database.  ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.  Visit ImpactRx at www.impactrx.com.CONTACT:Jennifer AguilarSagefrog Marketing Group, LLC215-230-9024jennifera@sagefrog.com
    '/>"/>

    SOURCE ImpactRx
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
    2. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
    3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
    4. CEL-SCI Corporation Releases Letter to Shareholders
    5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
    6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
    7. Immunosyn Corporation Releases SF-1019 Study Results
    8. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
    9. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
    10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
    11. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
    (Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
    (Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
    (Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
    (Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
    (Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
    (Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
    Breaking Medicine News(10 mins):